Immunosuppressive treatment in diffuse cutaneous systemic sclerosis is associated with an improved composite response index (CRISS)

BACKGROUND: Outcomes of therapeutic studies in diffuse cutaneous systemic sclerosis (dcSSc) have mainly been measured for specific organs, particularly the skin and lungs. A new composite response index in dcSSc (CRISS) has been developed for clinical trials. The goal of this study was to determine...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Boyang, Hudson, Marie, Wang, Mianbo, Baron, Murray
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7275378/
https://www.ncbi.nlm.nih.gov/pubmed/32503616
http://dx.doi.org/10.1186/s13075-020-02220-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7275378/
https://www.ncbi.nlm.nih.gov/pubmed/32503616
http://dx.doi.org/10.1186/s13075-020-02220-0

Ejemplares similares